Posted by Michael Wonder on 15 Oct 2022
Highlights from the 10-13 October 2022 CHMP meeting
14 October 2022 - The EMA’s CHMP recommended 10 medicines for approval at its October 2022 meeting.
The CHMP recommended granting a marketing authorisation for Dengue Tetravalent Vaccine (Live, Attenuated) Takeda for the prevention of dengue virus serotypes 1, 2, 3 and 4 in people from four years of age.
